Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Shigella”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Testing effectiveness (Phase 2)Looking for participantsNCT07049159
What this trial is testing

Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old

Who this might be right for
Shigella
Eveliqure Biotechnologies GmbH 72
Testing effectiveness (Phase 2)Study completedNCT01080716
What this trial is testing

Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate

Who this might be right for
DysenteryShigellaDiarrhea
U.S. Army Medical Research and Development Command 30
Early research (Phase 1)Study completedNCT03089879
What this trial is testing

Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or naïve Subjects Not Part of H03_01TP Study

Who this might be right for
Dysentery, Bacillary
GlaxoSmithKline 35
Testing effectiveness (Phase 2)Study completedNCT04865497
What this trial is testing

Immunogenicity and Safety of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 3 Months to 5 Years Old

Who this might be right for
DysenteryDysentery, Bacillary
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 1,050
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07666750
What this trial is testing

Safety and Immunogenicity Study of IP-QSV Vaccine in Healthy Adults/Adolescents, Children and Infants

Who this might be right for
Shigella Infection
International Vaccine Institute 370
Testing effectiveness (Phase 2)Study completedNCT04078022
What this trial is testing

Shigella CVD 30000: Study of Responses to Vaccination With Shigella Vaccine

Who this might be right for
Shigella
University of Maryland, Baltimore 58
Testing effectiveness (Phase 2)Looking for participantsNCT07433426
What this trial is testing

The Impact of Shigellosis and Recommended Treatment in Children

Who this might be right for
Diarrhea InfectiousShigellaGrowth & Development
Johns Hopkins Bloomberg School of Public Health 700
Large-scale testing (Phase 3)Study completedNCT00321126
What this trial is testing

Zinc Supplementation in Shigella Patients

Who this might be right for
Testing Effect of Intervention
International Centre for Diarrhoeal Disease Research, Bangladesh 56
Testing effectiveness (Phase 2)Study completedNCT06523231
What this trial is testing

Study to Expand Safety and Immunogenicity Data With Shigella Bioconjugate Vaccine (Shigella4V2) in 9-month-old Infants.

Who this might be right for
Shigellosis
LimmaTech Biologics AG 110
Post-approval studies (Phase 4)Study completedNCT03854929
What this trial is testing

Ciprofloxacin Versus Azithromycin for Children Hospitalised With Dysentery

Who this might be right for
Dysentery, ShigellaShigellosisDiarrhea
Oxford University Clinical Research Unit, Vietnam 364
Testing effectiveness (Phase 2)Study completedNCT02676895
What this trial is testing

The Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults

Who this might be right for
Shigella Sonnei Infection
GlaxoSmithKline 74
Not applicableStudy completedNCT02516683
What this trial is testing

The Long Term Clinical Course of Postinfectious Irritable Bowel Syndrome After Shigellosis; A 10 Year Follow up Study

Who this might be right for
Shigella Sonnei Infection
Yonsei University 229
Large-scale testing (Phase 3)Study completedNCT00742469
What this trial is testing

Rifaximin for Prevention of Travellers' Diarrhea

Who this might be right for
Diarrhea
Bausch Health Americas, Inc. 210
Early research (Phase 1)Study completedNCT02388009
What this trial is testing

Safety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a

Who this might be right for
Shigellosis
LimmaTech Biologics AG 30
Early research (Phase 1)Study completedNCT04634513
What this trial is testing

Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122

Who this might be right for
Shigella InfectionEnterotoxigenic Escherichia Coli Infection
University of Maryland, Baltimore 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT05182749
What this trial is testing

Safety and Efficacy of the Bacteriophage Preparation, ShigActive™, in a Human Experimental Model of Shigellosis

Who this might be right for
Shigellosis
Intralytix, Inc. 52
Large-scale testing (Phase 3)Study completedNCT00368316
What this trial is testing

Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel

Who this might be right for
Shigellosis
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 2,799
Testing effectiveness (Phase 2)Study completedNCT03527173
What this trial is testing

Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults

Who this might be right for
Dysentery, Bacillary
GlaxoSmithKline 71
Early research (Phase 1)Study completedNCT01369927
What this trial is testing

Shigella Sonnel O-SPC/rBRU Conjugate Vaccine

Who this might be right for
ImmunogenicityShigellosis
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 60
Testing effectiveness (Phase 2)Study completedNCT02646371
What this trial is testing

Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a

Who this might be right for
Shigellosis
LimmaTech Biologics AG 67
Next Page